glp-1 cancer receptor agonists in the context of cancer: the road ahead How Far beyond Diabetes Can
Description
I would not view them simply as weight-loss drugs
If deemed medically necessary, many GLP-1 medications are often covered by insurance
This is contrary to the results of a study by Bhagavathula et al
According to a Reuters article that inspired this blog, more than half of large employers are now signaling plans to reduce healthcare benefits in 2026 due to escalating GLP-1 and specialty drug costs
Future research should investigate the underlying mechanisms that mediate these effects
M., Szczepanski, L
